Physician profile
Niraj P Pandit
NPI 1740270198
$20,323.98
in general payments reported to CMS, 2019-2025
35 companies · $3,535 in 2025
The $3,535 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $417 · 2021: $578 · 2022: $1,508 · 2023: $1,047 · 2024: $1,568 · 2025: $3,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,614 · Travel and Lodging: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,614.01 |
| Travel and Lodging | $1,536.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,445.20 | 2019-2024 | |
| Medtronic, INC. | $4,490.85 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Linq II |
| Boston Scientific Corporation | $819.37 | 2019-2025 | Avvigo Guidance System, Rotapro, Ffr Link |
| Abiomed | $780.88 | 2019-2025 | Impella |
| Penumbra, INC. | $749.54 | 2019-2025 | Indigo System |
| Shockwave Medical, INC | $496.35 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $472.89 | 2019-2025 | Jot Dx, Gallant, Confirm Rx |
| Medtronic Vascular, INC. | $390.16 | 2019-2020 | |
| Cardiva Medical, INC. | $255.55 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Pfizer INC. | $204.99 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $146.47 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $133.14 | 2019-2021 | |
| Amgen INC. | $112.62 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $89.66 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.64 | 2019-2025 | Lifevest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $69.20 | 2024 | Biomonitor |
| Kiniksa Pharmaceuticals International, Plc | $66.08 | 2024 | Arcalyst |
| Atricure, INC. | $61.79 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Philips North America LLC | $49.78 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Irhythm Technologies, INC. | $49.77 | 2022-2023 | Zio Xt Patch |
| Acist Medical Systems, INC. | $48.11 | 2025 | |
| Astellas Pharma US INC | $45.86 | 2019 | |
| Edwards Lifesciences Corporation | $38.74 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Teleflex LLC | $33.21 | 2022-2023 | Manta |
| Merck Sharp & Dohme LLC | $30.12 | 2022-2023 | Verquvo |
| Cardiovascular Systems INC. | $25.58 | 2020 | |
| Abbvie INC. | $21.53 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $17.69 | 2022 | |
| Vital Connect, INC | $17.64 | 2025 | Vitalpatch Rtm |
| United Therapeutics Corporation | $16.74 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.73 | 2023 | Arcalyst |
| Stryker Corporation | $15.88 | 2019 | |
| Inari Medical, INC. | $15.19 | 2021 | |
| Baxter Healthcare | $15.03 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bardy Diagnostics, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Pandit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.